Information in this section pertains to all global PEN® partners except where country flags are
visible. Click on the flag(s) for country-specific information. If a country flag is not listed, there is
no information specific to that country.
[B] The following conclusions are supported by fair evidence:
In adults with type 1 diabetes, a meta-analysis of randomized, parallel and crossover studies reveals that continuous subcutaneous insulin infusion (CSII) results in better glycemic control, compared to multiple daily insulin injections (MDI), as evidenced by lower A1C levels.
Compared to multiple daily injections continuous subcutaneous insulin infusion use in children with type 1 diabetes may produce an improvement in glycemic